OTC Scar Treatment Market Segmented By Topical Scar Products for Atrophic Scars, Hypertrophic Scars and Keloids, Contractures, Burns, Stretch Marks
Industry: Healthcare
Published Date: September-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP33156
Worldwide revenue from the OTC scar treatment market reached US$ 8.4 Bn in 2021, with the market estimated to move ahead at a value CAGR of 3.8% to reach a valuation of US$ 12.6 Bn by the end of 2032.
According to Persistence Market Research, sales of topical scar products accounted for US$ 7.4 Bn in 2021. Overall, OTC scar treatment product sales accounted for 68.1% revenue share of the global scar treatment market in 2021.
| Report Attribute | Details |
|---|---|
|
OTC Scar Treatment Market Size (2022) |
US$ 8.7 Bn |
|
Projected Market Value (2032) |
US$ 12.6 Bn |
|
Global Market Growth Rate (2022-2032) |
3.8% CAGR |
|
Market Share of Top 5 Countries |
51.2% |
The global market for OTC scar treatment exhibited a CAGR of 2.8% over the 2012-2021 historical period.
Despite precautions taken after a trauma or surgical operation, dermal wounds largely heal by scarring, which can have extremely negative effects such as emotional distress, deformity, and reduced standard of living. The fear of stigma and social discomfort among patients with scar tissues emphasizes the importance of developing treatment options to restore scar tissues to healthy skin.
Multiple techniques and methods are effective in the management of scars. However, the growing incidence of scar tissue formation and its consequences on both, function and appearance, continue to place a financial strain on healthcare systems.
Wound treatment significantly increases the expense of healthcare in a nation, in addition to putting a lot of burden on patients and their families. Various therapeutic options exist, but they are often insufficient. Hydrogels are three-dimensional polymeric materials that can withstand considerable swelling without losing structural integrity. These unique properties make them ideal for use as topical wound therapy solutions in the form of films and as vehicles for drug delivery.
The most prevalent type of eczema is atopic dermatitis, a chronic, relapsing inflammatory skin condition characterized by dry skin, constant itching, and scaly lesions. Due to persistent itching and other related issues, including deformity, sleep difficulties, and social stigmatization brought on by visible lesions, this chronic condition significantly affects a patient's quality of life. Topical glucocorticoids, calcineurin inhibitors, and frequent use of moisturizers are the mainstays of atopic dermatitis treatment.
The global OTC scar treatment market is set to expand at 3.8% CAGR and reach a size of US$ 12.6 Bn by the end of 2032.
“Emergence of New Treatment Formulations”
Emollients (moisturizing treatments for direct application on the skin) have recently been enhanced with a variety of potent bioactive compounds to boost epidermal activity. These compounds are being researched more and more as atopic dermatitis treatment and prevention agents. Notably, these additions are grouped as cannabinoid receptor modulators, natural moisturising agents, physiological lipids and ceramide, and antioxidants.
Some active components have effectiveness levels that are on par with low- to medium-potency corticosteroids. These moisturizers with active ingredients also lead to improved treatment compliance, tolerability, and lowered corticosteroid use.
This presents an opportunity for manufacturers to promote their product offerings in the global market and will aid lucrative market growth during the forecasted years. Product adoption and accessibility are key to improving market penetration, and key players in the market are registering novel product portfolios in the market for distribution.
“Lack of Clinical Data on Product Efficacy”
Dermocosmetics are the subject of an increasing amount of research; however, it is important to remember that there is currently little clinical data supporting them. This is explained by the fact that most clinically tested formulations included a blend of several active ingredients or extracts. The reported efficacy of these multicomponent solutions may not accurately represent the biological action of a single active ingredient, but rather is most likely the result of the synergistic interactions of two or more substances.
A vast majority of the research uses inadequate study designs and limited sample sizes. Systemic examination of data and meta-analysis are both hampered by the absence of consistency in clinical assessment measures.
The lack of clinical data on the efficacy of OTC scar treatment products for a large population base is a restrictive factor for market growth.
How is the U.S. OTC Scar Treatment Market Faring?
“Rising Prevalence of Acne Aiding Product Sales”
The U.S. accounted for 85.3% share of the North America OTC scar treatment market in 2021. The U.S. market is expanding as a result of the easy accessibility of topical scar treatment products and growing disposable income in the nation.
With the easy availability of over-the-counter products to treat acne scars, the U.S. accounts for a large share of the global market for OTC scar treatment medications.
Why is Germany a Lucrative Market for OTC Scar Treatment Providers?
“Growing Research on Natural Compounds and Presence of Established Players”
Germany held 24% share of the Europe OTC scar treatment market in 2021.
The market for OTC scar treatment solutions in the country is expanding as a result of the presence of established manufacturers in Germany. Moreover, with growing epidemiological studies as well as research on the applicability of available biological compounds as ingredients in the form of gels for the treatment of scarring due to dermal conditions, the market is predicted to expand at a steady CAGR of 3.1% over the forecasted years.
What is China’s Stance in the Global Market for OTC Scar Treatment Services?
“Vast Applications of Traditional Chinese Medicine”
China accounted for a market share of 40.4% in the East Asia OTC scar treatment market in 2021 and accounted for 7.4% of the global market share.
Market growth in China is being driven by the presence of several products as a result of the proven efficacy of traditional Chinese medicines for the treatment of skin lesions.
Which OTC Scar Treatment Product is Most Widely Demanded?
“Huge Demand for Topical Scar Products across Regions”
Topical scar products held around 88.1% share of the market for OTC scar treatment in 2021.
Growing demand for non-invasive procedures for the management of scarring as well as rising consumer awareness with respect to available over-the-counter scar treatment products are factors that will drive the topical scar products segment over the forecasted years.
Which OTC Scar Treatment Application Accounts for a Notable Market Share?
“High Prevalence of Acne Causing Atrophic Scars”
Atrophic scars accounted for 38.7% share of the application of OTC scar treatment in 2021.
Atrophic scars mostly occur as a result of acne or diseases such as chicken pox. With a large population suffering from acne, the occurrence of atrophic scars is high as well. This segment thus presents a lucrative opportunity for OTC scar treatment product suppliers.
Key manufacturers of OTC scar treatment products are focusing on promoting their product portfolios through extensive marketing and product penetration strategies. The market for OTC scar treatment products is fragmented and key players are resorting to new product launches to enhance their global market presence.
For instance:
|
Attribute |
Details |
|---|---|
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2012-2021 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
By Product:
By Application:
By Distribution Channel:
By Region:
To know more about delivery timeline for this report Contact Sales
The global OTC scar treatment market was valued at US$ 8.4 Bn in 2021.
Sales of OTC scar treatment solutions are set to increase at 3.8% CAGR and reach US$ 12.6 Bn by 2032.
Demand for OTC scar treatment increased at 5.1% CAGR from 2012 to 2021.
The U.S., China, Canada, India, and Germany together account for 51.2% market share.
The U.S. accounts for 85.3% share of the North American OTC scar treatment market.
Smith & Nephew PLC, Merz Inc., and Enaltus LLC are the top suppliers of OTC scar treatment products.
China held a share of 40.4% in the East Asia OTC scar treatment market in 2021.
The Indian market is set to exhibit growth at a CAGR of 3.8% during the forecasted years.
